- /
- Supported exchanges
- / F
- / VTFN.F
Vitrolife AB (publ) (VTFN F) stock market data APIs
Vitrolife AB (publ) Financial Data Overview
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Vitrolife AB (publ) data using free add-ons & libraries
Get Vitrolife AB (publ) Fundamental Data
Vitrolife AB (publ) Fundamental data includes:
- Net Revenue: 3 507 M
- EBITDA: 1 031 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vitrolife AB (publ) News
New
Invitation to Vitrolife Group's presentation of the fourth quarter and full year report 2025
GOTHENBURG, Sweden, Jan. 20, 2026 /PRNewswire/ -- Vitrolife AB (publ) will publish its fourth quarter and full year report 2025 on Tuesday, 3 February 2026 at 08:00 am CET. A conference ...
European Value Stocks Trading Below Estimated Worth December 2025
As the pan-European STOXX Europe 600 Index hovers near record highs, buoyed by positive sentiment about future earnings and economic prospects, investors are increasingly on the lookout for stocks tra...
Vitrolife announces genetic services restructuring program targeting annualised savings of 65 MSEK and recognises a 5.4 BSEK goodwill impairment
GOTHENBURG, Sweden, Dec. 16, 2025 /PRNewswire/ -- Vitrolife AB (publ) ("Vitrolife") today announced that following a strategic review it will execute a restructuring program of its genetic services bu...
European Stocks Possibly Priced Below Intrinsic Value Estimates
Amid recent fluctuations in global markets, European stocks have faced pressure from concerns over AI valuations and shifting interest rate expectations. Despite these challenges, the expansion of bus...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.